Skip to main content

Cresco Labs Inc.

CRLBF
Exchange
OTC
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001832928

No open-market purchases or sales by Cresco Labs Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $122.7K in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Cresco Labs Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CRLBF: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders16116+1
Shares587.8K21.8K692.8K+126.8K (+22.4%)
Value$3.54M$131.0K$1.80M−$1.60M (−47.1%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Cresco Labs Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CRLBF in Q2 2022
InstitutionSharesValue% of portfolio
HighPoint Advisor Group LLC137,158$402.0K0.04%
Westerly Capital Management, LLC83,860$210.0K0.17%
MAI Capital Management10,641$27.0K0.00%
West Oak Capital, LLC250$1.00K0.00%

Sold out (3)

Institutions that held Cresco Labs Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CRLBF in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Fortitude Advisory Group L.L.C.8,243$49.0K
IFP Advisors, Inc791$5.00K
Tradition Wealth Management, LLC500$3.00K

Not filed for Q2 2022 yet (1)

Institutions that held Cresco Labs Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRLBF in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Carter Financial Group, INC.21,805$131.0K